Latest News 2019: At 6.1% CAGR, Glucagon Market will reach 700 Mn US$ by 2025: Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs

Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream.

Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.

GET FREE SAMPLE OF THIS PREMIUM REPORT AT https://inforgrowth.com/samplerequest/glucagon-market

The classification of glucagon includes inject glucagon and nasal glucagon, and now almost all the product is the type of injection. In 2018, Eli Lilly will launch the nasal glucagon in the market.

Glucagon is widely used in emergency kits, general use, diagnostic & motility, cardiogenic shock and another field. The most proportion of Glucagon is emergency kits, which is about 335 in2016.

North America is the largest consumption place, with a consumption market share nearly 41% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 25%.
Market competition is intense. Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

The global Glucagon market is valued at 430 million US$ in 2018 and will reach 700 million US$ by the end of 2025, growing at a CAGR of 6.1% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Glucagon market based on company, product type, end-user and key regions.

INQUIRE FOR DISCOUNT UPTO 50% ON GLUCAGON MARKET 2019-25 REPORT AT: https://inforgrowth.com/requestdiscount/glucagon-market

Key Players covered in this report are Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, Taj Pharmaceuticals, Xeris Pharmaceuticals.
Report analysed by applications like Emergency Kits, General Use, Diagnostic & Motility, Cardiogenic Shock, Others. Then report is analysed on the basis of product Inject Glucagon, Nasal Glucagon.

The Global Glucagon market analyzes and researches the Glucagon development status and forecast in United States, Europe, China, Japan, Southeast Asia, India & Central & South America.

The Glucagon Market report provides key statistics on the market status of the Glucagon manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

Major Points Covered in Table of Contents:
1 Study Coverage
2 Executive Summary
3 Breakdown Data by Manufacturers
4 Breakdown Data by Type
5 Breakdown Data by Application
6 North America
7 Europe
8 Asia Pacific
9 Central & South America
10 Middle East and Africa
11 Company Profiles
12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13 Value Chain and Sales Channels Analysis
14 Research Findings and Conclusion
15 Appendix

ASK FOR CUSTOM REQUIREMENTS OR QUERIES ABOUT THIS REPORT AT https://inforgrowth.com/samplerequest/glucagon-market

About InForGrowth:
We are a market-intelligence company formed with the objective of providing clients access to the most relevant and accurate research content for their growth needs. At InForGrowth, we understand Research requirements and help a client in taking informed business-critical decisions. Given the complexities and interdependencies of market-intelligence, there is always more than one source to explore and arrive at the right answer. Through our smart search feature and our reliable & trusted publishing partners, we are paving way for more simplified and relevant research.

For all your Research needs, reach out to us at:
Address: 6400 Village Pkwy suite # 104, Dublin, CA 94568, USA
Contact Person: Rohan
Email: sales@inforgrowth.com
US: +1-909-329-2808
UK: +44 (203) 743 1890

This release was published on openPR.